Afamitresgene autoleucel offers a novel approach to treating metastatic synovial sarcoma, with an overall response rate of 43.2% in clinical trials, providing a much-needed alternative to traditional chemotherapy.

The FDA advisory committee’s decision highlights the complexities of perioperative treatment in NSCLC and the need for more precise efficacy data to guide clinical decision-making.

Frailty assessment enables clinicians to predict outcomes, target interventions, and tailor clinical management for older adults, potentially improving care quality and patient outcomes.

Age bias in oncology can lead to younger patients receiving more aggressive treatments with marginal survival benefits, potentially compromising their quality of life.

Liver injuries tied to botanical supplements are on the rise, with cases nearly tripling in a decade. Healthcare providers should be aware of this growing concern and its implications for patient care.

A new study finds that 43% of dark chocolate products tested exceeded California’s Proposition 65 limits for lead, while 35% surpassed limits for cadmium.